Analysts: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

0.49USD
26 Dec 2014
Price Change (% chg)

$-0.03 (-5.58%)
Prev Close
$0.52
Open
$0.49
Day's High
$0.54
Day's Low
$0.47
Volume
158,349
Avg. Vol
82,055
52-wk High
$2.12
52-wk Low
$0.41

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 December 28 Dec 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 2 0.10 0.10 0.10 --
Quarter Ending Mar-15 1 15.10 15.10 15.10 --
Year Ending Dec-14 2 0.25 0.30 0.20 6.72
Year Ending Dec-15 2 9.05 15.70 2.40 19.45
Earnings (per share)
Quarter Ending Dec-14 2 -0.09 -0.08 -0.09 --
Quarter Ending Mar-15 1 0.23 0.23 0.23 --
Year Ending Dec-14 2 -0.31 -0.31 -0.31 -0.17
Year Ending Dec-15 2 -0.14 -0.01 -0.27 0.06

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 0.08 0.14 0.07 90.79
Quarter Ending Jun-14 0.07 0.04 0.04 51.72
Quarter Ending Mar-14 0.40 0.04 0.36 89.50
Quarter Ending Dec-13 0.22 0.04 0.18 83.72
Quarter Ending Sep-13 0.06 0.08 0.02 27.69
Earnings (per share)
Quarter Ending Sep-14 -0.08 -0.06 0.02 -20.00
Quarter Ending Jun-14 -0.08 -0.07 0.01 -12.50
Quarter Ending Mar-14 -0.05 -0.08 0.03 -60.00
Quarter Ending Dec-13 -0.06 -0.07 0.01 -16.67
Quarter Ending Sep-13 -0.07 -0.07 0.00 -0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 0.10 0.10 0.08 7.58 --
Quarter Ending Mar-15 15.10 15.10 15.10 -- --
Year Ending Dec-14 0.25 0.25 0.25 7.75 6.72
Year Ending Dec-15 9.05 9.05 9.06 1.56 19.45
Earnings (per share)
Quarter Ending Dec-14 -0.09 -0.09 -0.09 0.07 --
Quarter Ending Mar-15 0.23 0.23 0.23 -- --
Year Ending Dec-14 -0.31 -0.31 -0.31 -0.16 -0.17
Year Ending Dec-15 -0.14 -0.14 -0.14 -0.28 0.06

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 1 0
Quarter Ending Mar-15 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 1
Earnings
Quarter Ending Dec-14 0 0 0 0
Quarter Ending Mar-15 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks